摘要
背景:尽管在肿瘤生物学研究领域取得了许多进展,但在大多数情况下,包括化疗在内的常规治疗仍然是首选。主要缺点这些治疗方法,除了许多抗肿瘤药物的低溶解度外,还缺乏特异性,导致因非特异性药物的吸收而产生严重的副作用。你的细胞。 目的:回顾和分析肿瘤纳米治疗的最新进展。 结果:纳米技术的进步及其在医学上的应用为纳米技术的发展提供了新的机遇和不同的智能系统。这些系统可以改善药物在细胞内的释放。他们的多功能和目标潜力。首先,我们提供了癌症和目前在肿瘤学中使用的各种智能纳米粒子的全球概况。然后,对开发人员进行了详细的分析。肿瘤治疗中的药物传递策略,主要集中在静脉注射智能纳米粒子。最后,我们讨论了挑战,临床试验,市场上的纳米医学和纳米治疗在癌症治疗中的应用前景。 结论:在这篇综述中,我们证明了智能给药系统在提高现有标准治疗方式(包括化疗)治疗效果方面的巨大潜力。治疗和放射治疗。
关键词: 纳米医学,纳米粒子,药物传递,癌症治疗,纳米技术,放射治疗。
Current Drug Targets
Title:Smart Drug-Delivery Systems for Cancer Nanotherapy
Volume: 19 Issue: 4
关键词: 纳米医学,纳米粒子,药物传递,癌症治疗,纳米技术,放射治疗。
摘要: Background: Despite all the advances achieved in the field of tumor-biology research, in most cases conventional therapies including chemotherapy are still the leading choices. The main disadvantage of these treatments, in addition to the low solubility of many antitumor drugs, is their lack of specificity, which leads to the occurrence of severe side effects due to nonspecific drug uptake by healthy cells.
Objective: The purpose of this manuscript is to review and analyze the recent progress made in cancer nanotherapy.
Results: Progress in nanotechnology and its application in medicine have provided new opportunities and different smart systems. Such systems can improve the intracellular delivery of the drugs due to their multifunctionality and targeting potential. First, we provide a global overview of cancer and different smart nanoparticles currently used in oncology. Then, we analyze in detail the development of drug-delivery strategies in cancer therapy, focusing mainly on the intravenously administered smart nanoparticles. Finally, we discuss the challenges, clinical trials, marketed nanomedicines and future directions of the nanotherapy applied to cancer treatment.
Conclusión: In this review, we have evidenced the tremendous potential that smart drug-delivery systems have to enhance the therapeutic effect of current standard treatment modalities, including chemotherapies and radiotherapies.
Export Options
About this article
Cite this article as:
Smart Drug-Delivery Systems for Cancer Nanotherapy, Current Drug Targets 2018; 19 (4) . https://dx.doi.org/10.2174/1389450117666160527142544
DOI https://dx.doi.org/10.2174/1389450117666160527142544 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
Drug-Targeted Approach with Polymer Nanocomposites for Improved Therapeutics
Polymer nanocomposites have been recognized as an advanced and cutting-edge technique in drug targeting administration. These materials combine the unique features of nanoparticles with the adaptability of polymers to produce highly personalized drug administration devices. Integrating nanoparticles containing pharmaceuticals into a polymer matrix enables researchers to regulate the rates at ...read more
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
Therapeutic Chemical and RNA Design with Artificial Intelligence
Computer-Aided Drug Design (CADD) has emerged as a fundamental component of modern drug discovery. Molecular docking facilitates virtual screening on a large scale through structural simulations. However, traditional CADD approaches face significant limitations, as they can only screen known compounds from existing libraries. PubChem, as the most widely used chemical ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Effects of LPA and S1P on the Nervous System and Implications for Their Involvement in Disease
Current Drug Targets Endothelin Receptor Antagonists - An Overview
Current Medicinal Chemistry Phenomics of Vascular Disease: The Systematic Approach to the Combination Therapy
Current Vascular Pharmacology Big Science for Small Cells: Systems Approaches for Platelets
Current Drug Targets Endothelial Dysfunction: The Link Between Homocysteine and Hydrogen Sulfide
Current Medicinal Chemistry Role and Services of a Pharmacist in the Prevention of Medication Errors: A Systematic Review
Current Drug Safety Drug-Induced Hypokalaemia
Current Drug Safety A 30-years Review on Pharmacokinetics of Antibiotics: Is the Right Time for Pharmacogenetics?
Current Drug Metabolism A Review of the Therapeutic Benefits of Moringa oleifera in Controlling High Blood Pressure (Hypertension)
Current Traditional Medicine Effect of Aqueous Extract of Azadirachta indica Leaves on Pharmacokineics and Pharmacodynamics of Glipizide
Drug Metabolism Letters Smoking and Endothelial Progenitor Cells: A Revision of Literature
Current Pharmaceutical Design Adipose Tissue as a Regulator of Energy Balance
Current Drug Targets Strategies and Techniques for Multi-Component Drug Design from Medicinal Herbs and Traditional Chinese Medicine
Current Topics in Medicinal Chemistry Editorial [Hot topic: Low Grade Inflammation as a Common Pathogenetic Denominator in Age-Related Diseases: Novel Drug Targets for Anti-Ageing Strategies and Successful Ageing Achievement. Part II (Executive Editors: Calogero Caruso, Thea Magrone and Emilio Jirilllo)]
Current Pharmaceutical Design Antiplatelet Therapy in Acute Coronary Syndromes. Evidence Based Medicine
Current Pharmaceutical Design Circadian Rhythm of Blood Pressure in Diabetes Mellitus: Evidence, Mechanisms and Implications
Current Diabetes Reviews Antioxidant Therapy for Prevention of Inflammation, Ischemic Reperfusion Injuries and Allograft Rejection
Cardiovascular & Hematological Agents in Medicinal Chemistry Beyond Adding Years to Life: Health-related Quality-of-life and Functional Outcomes in Patients with Severe Aortic Valve Stenosis at High Surgical Risk Undergoing Transcatheter Aortic Valve Replacement
Current Cardiology Reviews Frailty of Older Age: The Role of the Endocrine - Immune Interaction
Current Pharmaceutical Design Preoperative and Follow up Multi-Detector Row CT Angiography (MDCTA) in the Evaluation of Interrupted Aortic Arch (IAA)
Current Medical Imaging